1Knight Cancer Institute, Oregon Health and Science University, Portland, OR
2Swedish Cancer Institute, Seattle, WA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.
Correspondence: Alexey V. Danilov (. e-mail: [email protected]).
Citation: Danilov AV, Pagel JM, Brown JR, Hill BT. Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?. HemaSphere, 2019;00:00–00. http://dx.doi.org/10.1097/HS9.0000000000000275.
The authors have indicated they have no potential conflicts of interest to disclose.
Funding: Alexey V. Danilov is a Leukemia and Lymphoma Society Scholar in Clinical Research.
Disclosures:
AVD: Aptose Biosciences: Research Funding; Verastem Oncology: Consultancy, Research Funding; Astra Zeneca: Consultancy, Research Funding; Gilead Sciences: Consultancy, Research Funding; Takeda Oncology: Research Funding; Genentech: Consultancy, Research Funding; TG Therapeutics: Consultancy; Bayer Oncology: Consultancy, Research Funding; Celgene: Consultancy.
JMP: Pharmacyclics, an AbbVie Company: Consultancy; Gilead: Consultancy.
JRB: Genentech: Consultancy; Celgene: Consultancy; Boehringer: Consultancy; Beigene: Membership on an entity's Board of Directors or advisory committees; Acerta / Astra-Zeneca: Consultancy; Abbvie: Consultancy; Verastem: Consultancy, Research Funding; Morphosys: Membership on an entity's Board of Directors or advisory committees; Pharmacyclics: Consultancy; Gilead: Consultancy, Research Funding; Sunesis: Consultancy; Invectys: Membership on an entity's Board of Directors or advisory committees; Novartis: Consulting; Sun Pharmaceutical Industries: Research Funding; Janssen: Consultancy; Loxo: Consultancy, Research Funding; TG Therapeutics: Consultancy; Roche/Genentech: Consultancy.
BTH: Seattle Genetics: Consultancy; Gilead: Consultancy; Seattle Genetics: Consultancy; Novartis: Consultancy; Seattle Genetics: Consultancy; Abbvie: Consultancy; Genentech: Honoraria, Consultancy, Research Funding; Amgen: Research Funding; Pharmacyclics: Consultancy.
AVD, JMP, JRB and BTH wrote the paper.
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0